Home | MyCME | All CME | Blog | Psychlopedia

Overview

Faculty

Activities in This Series

The Schizophrenia Remission Roller Coaster: Using Long-Acting Injectable Antipsychotics to Improve Adherence and Enhance Potential for Functional Recovery

Supported by educational grants from Alkermes, Inc., Otsuka America Pharmaceutical, Inc. and Lundbeck.

The goals of schizophrenia treatment are to control symptoms, prevent relapse, and improve functioning. For many patients, these goals are not being met. Long-acting injectable (LAI) antipsychotics can help patients get closer to achieving these goals. Learn from experts about the efficacy, safety, dosage, & administration of LAIs as well as about patient-centered care.

https://www.cmeinstitute.com/PublishingImages/series_home_images/series/MS19053.jpg
Brief Report
Prevalence and Impact of Schizophrenia Relapse

Prevalence and Impact of Schizophrenia Relapse

0.50 Credit | Rel 03/10/2020 | Exp 03/31/2022

The Schizophrenia Remission Roller Coaster: Using Long-Acting Injectable Antipsychotics to Improve Adherence and Enhance Potential for Functional Recovery

Supported by educational grants from Alkermes, Inc., Otsuka America Pharmaceutical, Inc. and Lundbeck.

The goals of schizophrenia treatment are to control symptoms, prevent relapse, and improve functioning. For many patients, these goals are not being met. Long-acting injectable (LAI) antipsychotics can help patients get closer to achieving these goals. Learn from experts about the efficacy, safety, dosage, & administration of LAIs as well as about patient-centered care.

https://www.cmeinstitute.com/PublishingImages/series_home_images/series/MS19053.jpg
Brief Report
Treatment Options for Schizophrenia

Treatment Options for Schizophrenia

1.00 Credit | Rel 03/31/2020 | Exp 03/31/2022

The Schizophrenia Remission Roller Coaster: Using Long-Acting Injectable Antipsychotics to Improve Adherence and Enhance Potential for Functional Recovery

Supported by educational grants from Alkermes, Inc., Otsuka America Pharmaceutical, Inc. and Lundbeck.

The goals of schizophrenia treatment are to control symptoms, prevent relapse, and improve functioning. For many patients, these goals are not being met. Long-acting injectable (LAI) antipsychotics can help patients get closer to achieving these goals. Learn from experts about the efficacy, safety, dosage, & administration of LAIs as well as about patient-centered care.

https://www.cmeinstitute.com/PublishingImages/series_home_images/series/MS19053.jpg
Brief Report
Patient-Centered Assessment in Schizophrenia

Patient-Centered Assessment in Schizophrenia

1.00 Credit | MOC | Rel 03/31/2020 | Exp 03/31/2022

The Schizophrenia Remission Roller Coaster: Using Long-Acting Injectable Antipsychotics to Improve Adherence and Enhance Potential for Functional Recovery

Supported by educational grants from Alkermes, Inc., Otsuka America Pharmaceutical, Inc. and Lundbeck.

The goals of schizophrenia treatment are to control symptoms, prevent relapse, and improve functioning. For many patients, these goals are not being met. Long-acting injectable (LAI) antipsychotics can help patients get closer to achieving these goals. Learn from experts about the efficacy, safety, dosage, & administration of LAIs as well as about patient-centered care.

https://www.cmeinstitute.com/PublishingImages/series_home_images/series/MS19053.jpg
Brief Report
Patient-Centered Care for Schizophrenia

Patient-Centered Care for Schizophrenia

0.50 Credit | MOC | Rel 04/29/2020 | Exp 04/30/2022

The Schizophrenia Remission Roller Coaster: Using Long-Acting Injectable Antipsychotics to Improve Adherence and Enhance Potential for Functional Recovery

Supported by educational grants from Alkermes, Inc., Otsuka America Pharmaceutical, Inc. and Lundbeck.

The goals of schizophrenia treatment are to control symptoms, prevent relapse, and improve functioning. For many patients, these goals are not being met. Long-acting injectable (LAI) antipsychotics can help patients get closer to achieving these goals. Learn from experts about the efficacy, safety, dosage, & administration of LAIs as well as about patient-centered care.

https://www.cmeinstitute.com/PublishingImages/series_home_images/series/MS19053.jpg
Academic Highlights
Potential of LAIs in Schizophrenia Recovery

Potential of LAIs in Schizophrenia Recovery

1.00 Credit | Rel 06/30/2020 | Exp 08/31/2022